http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9539204-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_241c3d4e236532a2e822eb39f56b1be9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-14
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d62b1e782119126042aac7bdb9cea4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_770abdb6c4c27fde6f0c3cd81f453ccc
publicationDate 2017-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9539204-B2
titleOfInvention Therapeutic or preventive agent for meibomian gland dysfunction or meibomian gland blockage
abstract The objective of the present invention is to provide a new medicinal use of clarithromycin. The present invention is a therapeutic agent or a preventive agent for meibomian gland dysfunction or meibomian gland blockage and comprises clarithromycin as an active ingredient. The dosage form is preferably an eye drop or eye ointment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11419886-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10143761-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11554134-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9999594-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017071852-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015125395-A1
priorityDate 2012-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H11147827-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011106697-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005043222-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0692850-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011206620-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2291694-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5629297-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7811599-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006241172-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284534
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396434
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45051774
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226401893
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73950587
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393816
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84029
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393829
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393830

Total number of triples: 57.